Pfizer Inc., et al. v. Mylan, Inc., et al., C.A. No. 15-26 - SLR, May 5, 2016.

Robinson, J. Claim construction opinion issues regarding one term from one patent.

The disputed technology relates to a form of tigecycline. The following term was considered:

  1. “Form I tigecycline having X-ray powder diffraction peaks at about ...”